Less global COVID-19 data spurs worries of missing a variant

Researchers are concerned about whether the next COVID-19 variant of concern will be spotted in time as multiple countries are constricting their surveillance work, Nature reported Jan. 24. 

Advertisement

China’s near silence on COVID-19 reporting has some infectious disease experts worrying about delayed information on the coronavirus changing and potentially having to play catch-up. 

Since the onset of the pandemic, most countries tracked variants by targeted sequencing of hospitalized patients to discover more severe variants and from immunocompromised patients with lengthy infections because extended cases can lead to a heavily mutated virus, according to Nature. The constant sequencing has leveled off for the past year, however. 

A rapid boost in a new variant’s number of mutations attracts attention as a potential variant of concern, which can be one that has stronger evasion to immunity protections, causes more severe disease or is more transmissible, Nature reported. If there are fewer eyes on a potential spike in a variant’s mutation number, regional and national responses can be deferred. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.